Company:  GENOMIC HEALTH INC (GHDX)
Form Type:  10-K
Filing Date:  3/14/2012 
CIK:  0001131324 
Address:  301 PENOBSCOT DRIVE 
City, State, Zip:  REDWOOD CITY, California 94063 
Telephone:  650-556-9300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$26.46  
Change: 
-0.30 (-1.12%)  
Trade Time: 
Apr 24  
Market Cap: 
$825.13M
Description of Business
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this report, the words "expects," "anticipates," "intends," "estimates," "plans," "believes," and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include statements about our expectation that, for the foreseeable future, a significant amount of our revenues will be derived from Oncotype DX for invasive breast cancer; the factors that may impact our financial results; our ability to achieve sustained profitability; our business strategy and our ability to achieve our strategic goals; our expectations regarding product revenues and the sources of those revenues; the amount of future revenues that we may derive from Medicare patients or categories of patients; our belief that we may become more dependent on Medicare reimbursement in the future; our plans to pu
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. Business.
      ITEM 1A. Risk Factors.
      ITEM 1B. Unresolved Staff Comments.
      ITEM 2. Properties.
      ITEM 3. Legal Proceedings.
      ITEM 4. Mine Safety Disclosures.
        NAME AND TITLE
    PART II
      ITEM 5. Market for Registrant's Common Equity, Related ...
      ITEM 6. Selected Financial Data.
        BALANCE SHEET
      ITEM 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      ITEM 7A. Quantitative and Qualitative Disclosures About ...
      ITEM 8. Financial Statements and Supplementary Data.
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          Note 12. Subsequent Event (Unaudited)
      ITEM 9. Changes in and Disagreements with Accountants on ...
      ITEM 9A. Controls and Procedures.
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
      ITEM 9B. Other Information.
    PART III
      ITEM 10. Directors, Executive Officers and Corporate ...
      ITEM 11. Executive Compensation.
      ITEM 12. Security Ownership of Certain Beneficial Owners ...
      ITEM 13. Certain Relationships and Related Transactions, ...
      ITEM 14. Principal Accounting Fees and Services.
    PART IV
      ITEM 15. Exhibits and Financial Statement Schedules.
    VALUATION AND QUALIFYING ACCOUNTS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 10.17
  EXHIBIT 12.1
    RATIO COMPUTATION
  EXHIBIT 21.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
  EXHIBIT 32.2
BROKERAGE PARTNERS